Evidence map›Paper›PMID 42147354›Full record

ArticleCancer communications (London, England)2026

Dysregulated Proline Metabolism Exacerbates Hepatocellular Carcinoma Metastasis via EPRS1-Mediated mRNA Translation.

Hui Zhang, Leirong Gu, Xiameng Su, Wanjin Chen, Ming Tan, Haibo Yu, Hongzhong Zhou, Tingting Gao, Zhiling Wang, Xinyan Chen and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hui ZhangDepartment of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Leirong GuDepartment of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Xiameng SuDepartment of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Wanjin ChenDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Ming TanDepartment of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China.
Haibo YuDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Hongzhong ZhouDepartment of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Health Science Center, Shenzhen University, Shenzhen, Guangdong, P. R. China.
Tingting GaoDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Zhiling WangDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Xinyan ChenDepartment of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Weixian ChenDepartment of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Juan ChenDepartment of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
Shengtao ChengDepartment of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsProlineAnimalsCell Line, TumorGene Expression Regulation, NeoplasticHumansMaleMetabolic ReprogrammingMiceMice, NudeNeoplasm MetastasisProtein BiosynthesisRNA, MessengerProlineRNA, Messenger

Identifiers

PMID42147354
PMCPMC13172588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.